The Chinese tech giant will be the publisher in a few Asian countries (also handling their localization), plus it will develop a mobile version.
The Finnish company announced on its website that the agreement with the Chinese means Remedy Entertainment’s free-to-play cooperative shooter game, Vanguard, will get an international release. The developer and the publisher will be Remedy, except for a few Asian countries, where Tencent will be the publisher (and, due to localization, it will be available in China, too). “Vanguard marks Remedy’s first entry into Games-as-a-Service business model, executed by our top tier team of free-to-play experts.
We are building something new and exciting for cooperative multiplayer space, on top of Remedy’s strengths. Expanding our capabilities to take on publishing responsibilities is the next step in developing our company. We are excited about this long-term partnership with Tencent and, with confidence, can say that it is an excellent fit in supporting Vanguard’s ambitious plans. Vanguard is a global opportunity, and Tencent can help Remedy internationally and lead the operations in Asia and the mobile markets,” said Remedy Entertainment CEO Tero Virtala in a press release.
And here’s the announcement: “The game codenamed Vanguard (“the game”), Remedy’s original intellectual property, is a free-to-play, cooperative PvE shooter that combines Remedy’s narrative expertise and action gameplay into an immersive multiplayer experience. The game is developed with the Unreal Engine for PC and console platforms. Remedy will develop and publish the game worldwide, excluding selected Asian markets, where Tencent will localize and publish the game.
The game’s development is currently in the proof-of-concept phase. Its development budget up to the end of the first year of live operations will be in the range of a typical Remedy AAA game budget. This development will be co-financed by Remedy and Tencent. In addition, Tencent will localize the game for the selected Asian markets and cover the related localization costs.
Remedy and Tencent will be responsible for their publishing and game operating costs in their respective territories while sharing a portion of revenue to the other party after the recoupment of the development costs. Remedy has also licensed Tencent worldwide rights to develop and publish a mobile version of the game as part of the agreement. Tencent will cover the costs for creating and publishing the mobile version. The parties have agreed on a separate revenue sharing scheme for the mobile version,” the statement reads.
The Chinese expansion (which also includes NetEase) is unstoppable.